Author/Authors :
RAUF, M.K. University of Health Sciences - Fatima Memorial Hospital - Department of Medicine, Pakistan , KHAN, A.Z. University of Health Sciences - Fatima Memorial Hospital - Department of Medicine, Pakistan , BASIT, M.B. University of Health Sciences - Fatima Memorial Hospital - Department of Medicine, Pakistan
Abstract :
Background and Objective: Obesity is now considered as an emerging epidemic worldwide. It is asso-ciated with dyslipidemias and is considered independent cardiovascular risk. The objective of the study was to determine the frequency of dyslipidemias in normotensive and non-diabetic obese subjects. Methods: A descriptive study of case series was conducted at Fatima Memorial Hospital Medical Out-patient Department from 01-01-2015 to 30-06-2015. Fifty obese non-diabetic participants with normal blood pressures were included in this study. Body weight in kilograms and height in centimeters was measured to calculate Body Mass Index (BMI) and Waist Hip circumference was also measured. All stu-dy participants were investigated for fasting lipid profile. Results: The mean age of the participants was 43.02 ± 7.90 years. The mean BMI was 35.23 ± 4.42. The mean Waist circumference was 95.68 ± 18.67 cms. The mean Hip circumference was 103.02 ± 20.04 cms. The mean Waist/Hip ratio of the participants was 0.93 ± 0.05. 36/50 (72%) participants had 200 mg/dl total cholesterol, 33/50 (66%) participants with 150 mg/dl triglycerides, 27/50 (54%) participants with 130 mg/dl low density lipoproteins – cholesterol and 21/50 (42%) participants with 40 mg/dl high density lipoproteins – cholesterol. There were 42/50 (84%) subjects having dyslipide-mia only 08/50 (16%) participants were without any deranged lipid profile. The statistical test between two percentages was significant with p value .03. Conclusion: It is concluded from the study that non-diabetic, normotensive albeit obese subjects have higher frequency of dyslipidemia as it was found in 84% of the study participants and therefore are at a higher risk for CVD.